Australia's largest stock trading and investment forum Australia's #1 stock forum

SP1

0.00%

$1.07 southern cross payments ltd

Ann: Cont Disclosure Independent Expert Report & Supplementary, page-25

First 25 Last

Share
Profile

Follow
A4paper

3,828 Posts.

452

07/09/20

17:08

Post #: 47150032
Share

Originally posted by Gsinc: ↑

Ah good pickup.

So the below was the last correspondence from ASX regarding requirements:

Any decision by ASX to reinstate ISX’s shares to quotation will, in the usual way, be conditional on ASX
being satisfied at the time that ISX is in material compliance with its obligations under the listing rules
(including, in particular its continuous and periodic disclosure obligations in chapters 3 and 4, and its
ongoing obligations in chapter 12) and that it is otherwise appropriate to do so.”

Without limitation, in considering whether it is appropriate to reinstate ISX’s shares to quotation, ASX will have
regard to the following further breaches of the listing rules which have not been rectified by ISX:

• ISX’s breach of listing rule 18.7 for failing to provide a satisfactory response to ASX’s query letter
regarding ISX’s disclosures in relation to its arrangements with Visa (see ASX’s Market Announcement
dated 25 May 2020)11; and
• ISX’s breach of listing rule 18.7 for failing to provide information requested by ASX in relation to
certain shareholder requisitions (see ASX’s Market Announcement dated 17 June 2020).

Expand

Escrow 'proofs' and/or ASIC the only 'unclear' hurdles left it seems.

Lets trade this thing.

Last edited by A4paper: 07/09/20

ISX Price at posting: $1.07 Sentiment: None Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BUX

Buxton projects new graphite province discovery at WA Narryer play

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 144 more messages in this thread...

First 25 Last

Add SP1 (ASX) to my watchlist

Ann: Cont Disclosure Independent Expert Report & Supplementary, page-25

Top Stories

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BCI reaches close of funding facility for salt-first part of Mardie project

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Buxton projects new graphite province discovery at WA Narryer play

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News